Iovance Biotherapeutics Inc. Stock
The price for the Iovance Biotherapeutics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.046 (-0.550%).
With 21 Buy predictions and 3 Sell predictions Iovance Biotherapeutics Inc. is one of the favorites of our community.
With a target price of 26 € there is potential for a 217.54% increase which would mean more than doubling the current price of 8.19 € for Iovance Biotherapeutics Inc..
So far the community has only identified positive things for Iovance Biotherapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Iovance Biotherapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Iovance Biotherapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Iovance Biotherapeutics Inc. | -0.550% | -11.212% | -25.833% | 0.392% | 4.867% | -45.918% | - |
Ironwood Pharmaceuticals | 5.450% | 0.917% | -24.138% | -46.078% | -46.078% | -41.489% | - |
Novocure Ltd | -0.580% | -4.920% | 76.819% | -69.807% | 42.137% | -87.839% | - |
United Therapeutics | -2.080% | 0.955% | 15.476% | 29.307% | 27.970% | 65.817% | 230.769% |
Comments
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Show more
Ratings data for IOVA provided by MarketBeat